⌘K

THRD

NASDAQ

Third Harmonic Bio Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2022

News25/Ratings6

Latest news

25 items

252dINSIDER
CEO Holles Natalie C. disposed of 1,218,836 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
Director Seidel Hans Martin disposed of 85,753 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
SEC Form 4 filed by Director Soloway Thomas P
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
Director Iwicki Mark T disposed of 128,631 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
SEC Form 4 filed by Chief Financial & Bus. Officer Murphy Christopher M.
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
SEC Form 4 filed by Director Gladstone Michael
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
252dINSIDER
Director Bonita David P disposed of 5,779,071 shares, closing all direct ownership in the company (SEC Form 4)
4 - Third Harmonic Bio, Inc. (0001923840) (Issuer)
255dSEC
SEC Form 15-12G filed by Third Harmonic Bio Inc.
15-12G - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form EFFECT filed by Third Harmonic Bio Inc.
EFFECT - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form S-8 POS filed by Third Harmonic Bio Inc.
S-8 POS - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form POS AM filed by Third Harmonic Bio Inc.
POS AM - Third Harmonic Bio, Inc. (0001923840) (Filer)
266dSEC
SEC Form 25 filed by Third Harmonic Bio Inc.
25 - Third Harmonic Bio, Inc. (0001923840) (Filer)
276dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
315dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
315dPR
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025 THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation Company initiating a sale process of THB335 SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD) today announced that its stockholders overwhelmingly approved the previously proposed Plan of Liquidation and
316dSEC
SEC Form 8-K filed by Third Harmonic Bio Inc.
8-K - Third Harmonic Bio, Inc. (0001923840) (Filer)
343dSEC
SEC Form SCHEDULE 13G filed by Third Harmonic Bio Inc.
SCHEDULE 13G - Third Harmonic Bio, Inc. (0001923840) (Subject)
343dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Third Harmonic Bio Inc.
SCHEDULE 13G/A - Third Harmonic Bio, Inc. (0001923840) (Subject)
346dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Third Harmonic Bio Inc.
SCHEDULE 13G/A - Third Harmonic Bio, Inc. (0001923840) (Subject)
350dSEC
SEC Form 10-Q filed by Third Harmonic Bio Inc.
10-Q - Third Harmonic Bio, Inc. (0001923840) (Filer)
363dSEC
SEC Form DEFA14A filed by Third Harmonic Bio Inc.
DEFA14A - Third Harmonic Bio, Inc. (0001923840) (Filer)